Product Information

SIROLIMUS 1 MG/ML SOLUTION is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $4.2095 per ML under NDC 59762120506. Its NADAC has been published 240 times since Feb 17, 2021.

FDA first approved this application on Sep 15, 1999. Its Orange Book therapeutic-equivalence code is AA.

SIROLIMUS 1 MG/ML SOLUTION

sirolimus
$4.2095per ML

Strength

1 mg/mL

NDC

59762120506

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

SIROLIMUS

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021083

FDA Approved

9/15/1999

TE Code

AA

On Market Since

7/22/2019

Pharmacological Classes

Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price Statistics

The NADAC for SIROLIMUS 1 MG/ML SOLUTION has been published 240 times since Feb 17, 2021, and over the history we have for it it has declined 74.8%. The table below summarizes its recorded NADAC range and movement.

Current price$4.2095 per ML
All-time high$16.6782 (Feb 16, 2022)
All-time low$4.2095 (Oct 21, 2026)
52-week high$5.2539
52-week low$4.2095
Median price$6.9877
Average price$8.5462
Largest weekly change-48.4% (Feb 23, 2022)
Weeks tracked240
Tracking sinceFeb 17, 2021

Price History

1W

0.0%

1M

-4.1%

3M

-14.2%

6M

-16.7%

1Y

-14.0%

3Y

-51.1%

5Y

-74.8%

All

-74.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SIROLIMUS 1 MG/ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for SIROLIMUS 1 MG/ML SOLUTION, manufactured by Mylan Pharmaceuticals Inc., is $4.2095 per ML (NDC 59762120506), effective Nov 11, 2026.

How has the price of SIROLIMUS 1 MG/ML SOLUTION changed over time?

Over the history we have for it, the NADAC for SIROLIMUS 1 MG/ML SOLUTION has declined 74.8%. It has been tracked across 240 weekly CMS publications since Feb 17, 2021.

What are the highest and lowest recorded NADAC prices for SIROLIMUS 1 MG/ML SOLUTION?

Since Feb 17, 2021, the NADAC for SIROLIMUS 1 MG/ML SOLUTION has ranged from a low of $4.2095 (Oct 21, 2026) to a high of $16.6782 (Feb 16, 2022), with a median of $6.9877 per ML.

Are there cheaper alternatives to SIROLIMUS 1 MG/ML SOLUTION?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SIROLIMUS 1 MG/ML SOLUTION in a comparable dosage form, but none are currently priced below it.

Who manufactures SIROLIMUS 1 MG/ML SOLUTION?

SIROLIMUS 1 MG/ML SOLUTION (NDC 59762120506) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.